These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2352480)

  • 21. The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia.
    Segawa M; Hirata Y; Fujimori S; Okada K
    Metabolism; 1988 May; 37(5):454-60. PubMed ID: 3285132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
    Kumar S; Arun KH; Kaul CL; Sharma SS
    Neurol Res; 2005 Jan; 27(1):60-6. PubMed ID: 15829161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transition metals and polyol pathway in the development of diabetic neuropathy in rats.
    Nakamura J; Hamada Y; Chaya S; Nakashima E; Naruse K; Kato K; Yasuda Y; Kamiya H; Sakakibara F; Koh N; Hotta N
    Diabetes Metab Res Rev; 2002; 18(5):395-402. PubMed ID: 12397582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axonal transport and nerve conduction and their relation to nerve polyol and myo-inositol levels in spontaneously diabetic BB/D rats.
    Mayer JH; Herberg L; Tomlinson DR
    Neurochem Pathol; 1984-1985 Winter; 2(4):285-93. PubMed ID: 6085698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
    Engerman RL; Kern TS
    Diabetes; 1993 Jun; 42(6):820-5. PubMed ID: 8495805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 4-methylcatechol on sciatic nerve growth factor level and motor nerve conduction velocity in experimental diabetic neuropathic process in rats.
    Hanaoka Y; Ohi T; Furukawa S; Furukawa Y; Hayashi K; Matsukura S
    Exp Neurol; 1992 Feb; 115(2):292-6. PubMed ID: 1735473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nerve conduction velocity and axonal transport of 6-phosphofructokinase activity in galactose-fed rats.
    Willars GB; Calcutt NA; Tomlinson DR
    J Neurol Sci; 1991 Jul; 104(1):46-51. PubMed ID: 1717661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal polyol and myo-inositol in galactosemic dogs given an aldose-reductase inhibitor.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3175-7. PubMed ID: 1748548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
    Pop-Busui R; Marinescu V; Van Huysen C; Li F; Sullivan K; Greene DA; Larkin D; Stevens MJ
    Diabetes; 2002 Aug; 51(8):2619-28. PubMed ID: 12145179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T; Nakamura J; Koh N; Sakakibara F; Hamada Y; Sasaki H; Naruse K; Nakashima E; Takeuchi N; Inukai S
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA; Cameron NE; Hohman TC
    J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosine.
    Saini AK; Arun KH; Kaul CL; Sharma SS
    Pharmacol Res; 2004 Dec; 50(6):593-9. PubMed ID: 15501697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the peptide HP228 on nerve disorders in diabetic rats.
    Calcutt NA; Dines KC; Ceseña RM
    Metabolism; 1998 Jun; 47(6):650-6. PubMed ID: 9627361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats.
    Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Komori H; Sakamoto N
    Diabetes; 1992 May; 41(5):587-91. PubMed ID: 1533192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nerve conduction and antioxidant levels in experimentally diabetic rats: effects of streptozotocin dose and diabetes duration.
    Van Dam PS; Van Asbeck BS; Bravenboer B; Van Oirschot JF; Marx JJ; Gispen WH
    Metabolism; 1999 Apr; 48(4):442-7. PubMed ID: 10206435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galactosemic neuropathy in transgenic mice for human aldose reductase.
    Yagihashi S; Yamagishi S; Wada R; Sugimoto K; Baba M; Wong HG; Fujimoto J; Nishimura C; Kokai Y
    Diabetes; 1996 Jan; 45(1):56-9. PubMed ID: 8522060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes.
    Whiteley SJ; Tomlinson DR
    Exp Neurol; 1985 Aug; 89(2):314-21. PubMed ID: 3160601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet aggregation in experimental diabetes and experimental galactosemia.
    Kern TS; Engerman RL
    Diabetes; 1984 Sep; 33(9):846-50. PubMed ID: 6381180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.